350 likes | 497 Views
Pneumonia. Andriy Lepyavko, MD, PhD Department of Internal Medicine № 2. Definition. Pneumonia – this is an inflammation in the lung parenchyma caused by bacteria, viruses or fungi which is characterized by intraalveolar exudation. Morphology. Classification. Etiology (if it is known)
E N D
Pneumonia Andriy Lepyavko, MD, PhD Department of Internal Medicine № 2
Definition • Pneumonia – this is an inflammation in the lung parenchyma caused by bacteria, viruses or fungi which is characterized by intraalveolar exudation
Classification • Etiology (if it is known) • Variants: • Community-acquired pneumonia • Nosocomial pneumonia – when patient was hospitalized with any another diagnosis, and after 48 hours in the hospital (not earlier!) pneumonia was diagnosed, or pneumonia after artificial lung ventilation • Pneumonia due to aspiration. It results from the aspiration of gastric contents in addition to aspiration of upper respiratory flora in secretions. • Pneumonia in immunocompromised host – patients with AIDS or immunodeficit of other origin. Causes of pneumonia – viruses, fungi of saprofites (E.coli etc.)
Classification III. Localization (side, lobe, segment) IV. Stages of severity: • Mild stage –conciousness is clear, t less than 38, heart rate less than 90, BP normal, dyspnea mild in case of physical activity, CXR – small infiltration • Moderate – conciousness is clear, sweating, general weakness, t 38-39, heart rate 90-100, moderate dccreased BP, dyspnea, large size of infiltration • Severe – t 39-40, conciousness is not clear, heart rate more than 100, low BP, severe dyspnea, cyanosis, large size of infiltration and presence of complications V. Complications.
Pathogenesis • Route of entry - Inhalation - Aspiration - Bloodborne • Host/ organism dynamics tipped by - Defect in host defences - Virulent organism - Overwhelming inoculum
Host Defences • Nasal hair • Dynamics of airflow • Cough • Mucous • Mucociliary apparatus • Bacterial interference • Immunoglobulin • Surfactant • Fibronectin • Complement • Cytokines • Alveolar macrophages • Polymorphonuclear leucocytes • Cell-mediated immunity
Diagnostic criteria • Predisposition – CHF, diabetes, alcoholism, COPD • Classic symptoms – cough, fever, sputum production, dyspnea • Clinical syndrome – fever, pleuritic chest pain, productive cough with mucopurulent sputum • Focal pulmonary findings (rales, crapitation or signs of consolidation) – less sensitive than CXR • General blood analysis – increased ESR, leucocytosis, shift to the left • Sputum analysis – causative microorganism and its sencitivity to antibiotics may be found
Diagnostic criteria • CXR with infiltrates – diagnosis “pneumonia” is invalid without it
Community-acquired pneumonia Most common pathogens: • Streptococcus pneumoniae (9% to 75%; mean, 33%), • Haemophilus influenzae (0 to 50%; mean, 10%), • Legionella species (0 to 50%; mean, 7%), • Chlamydia pneumoniae (0 to 20%; mean, 5%). • Mycoplasma pneumoniae
Community Acquired Pneumonia Incidence # in 1000s Adeel A. Butt, MD
Community Acquired Pneumonia Mortality # in 1000s Adeel A. Butt, MD
Duration of treatment • At least 5 days • Until afebrile for 48-72 hours • Stable vital signs • Longer course needed if Initial antibiotic choice did not cover the pathogen Extrapulmonary infection (meningitis) Lung abscess, cavitation or empyema Gram negative pathogen or S.aureus
Nosocomialpneumonia • Staphylococcus aureus • Gram-negative microorganisms - Pseudomonas, Klebsiella, Proteus, enterobacteria, E.coli • Fungi - Candida, Aspergillus, Rizopus.
Aspiration pneumonia Most effective are: • Aminoglycozyde (tobramycin, sizomycin)+ Metronidazol • Cephalosporini III-IV generation+Metronidazol